Identifying new strategies to combat cytomegalovirus by integrating existing and innovative approaches in diagnosis and treatment
- 3 October 2025
- journal article
- Published by Taylor & Francis in Future Virology
- Vol. 20 (10) , 379-395
Abstract
No abstract availableThis publication has 176 references indexed in Scilit:
- Analysis of an Expanded Targeted Early Cytomegalovirus Testing ProgramOtolaryngology–Head and Neck Surgery, 2023
- Time‐dependent prediction of mortality and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation using machine learningAmerican Journal of Hematology, 2022
- Co‐Delivery of Precisely Prescribed Multi‐Prodrug Combination by an Engineered Nanocarrier enables Efficient Individualized Cancer ChemotherapyAdvanced Materials, 2022
- Immunotherapy with adoptive cytomegalovirus‐specific T cells transfer: Summarizing latest gene engineering techniquesHealth Science Reports, 2021
- Comparing cytomegalovirus diagnostics by cell culture and quantitative nucleic acid testing in broncho‐alveolar lavage fluidsJournal of Medical Virology, 2020
- Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate MofetilThe Journal of Clinical Pharmacology, 2019
- Cytomegalovirus latency and reactivation: recent insights into an age old problemReviews in Medical Virology, 2015
- Cytomegalovirus Reactivation in Critically Ill Immunocompetent PatientsJAMA, 2008
- New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infectionReviews in Medical Virology, 2007
- Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoproteinEuropean Journal of Immunology, 2002